Showing results (291-300 of 344) with videos related to
Sort By:
Pageof 35
Journal of Clinical Medicine|June 29, 2019
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma NetworkConcetta Conticello, Alessandra Romano, Vittorio Del Fabro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2013
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical featuresFortunato Morabito, Laura Mosca, Giovanna Cutrona, et al.Annals of Hematology|April 12, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life studySalvatore Leotta, Uros Markovic, Andrea Duminuco, et al.Blood Advances|September 15, 2021
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?Alessandra Tedeschi, Anna Maria Frustaci, Francesca Romana Mauro, et al.Journal of Cancer Research and Clinical Oncology|April 21, 2018
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysisChiara Cerrato, Francesco Di Raimondo, Lorenzo De Paoli, et al.American Journal of Hematology|October 23, 2016
A population-based study of chronic myeloid leukemia patients treated with imatinib in first lineFausto Castagnetti, Francesco Di Raimondo, Antonio De Vivo, et al.Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.American Journal of Hematology|April 2, 2020
Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III studyFrédéric Baron, Fabio Efficace, Laura Cannella, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survivalAntonio Palumbo, Sara Bringhen, Alessandra Larocca, et al.Blood|January 15, 2005
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocolMarco Mancini, Daniela Scappaticci, Giuseppe Cimino, et al.Pageof 35